US Stock MarketDetailed Quotes

IRD Opus Genetics

Watchlist

0.984
+0.004+0.42%

Close Nov 21 16:00 ET

0.984
0.0000.00%

Post 20:01 ET

31.07MMarket Cap-902P/E (TTM)

Opus Genetics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Opus Genetics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q1	-- / 2.000M	--
--	2024/Q4	-- / 11.104M	--
--	2024/Q3	3.867M / 2.296M	--
--	2024/Q2	1.112M / 1.942M	--
--	2024/Q1	1.711M / 4.670M	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q1-- / 2.000M--

--2024/Q4-- / 11.104M--

--2024/Q33.867M / 2.296M--

--2024/Q21.112M / 1.942M--

--2024/Q11.711M / 4.670M--

Unlock Free Earnings Estimates

Open Account

Opus Genetics Earnings Reports

Opus Genetics | 10-Q: Q3 2024 Earnings Report

Nov 12 09:40 ET

Ocuphire Pharma | 10-Q: Q2 2024 Earnings Report

Aug 13 16:12 ET

Ocuphire Pharma | 10-Q: Q1 2024 Earnings Report

May 10 16:41 ET

Ocuphire Pharma | 8-K: Ocuphire Pharma Announces Financial Results for First Quarter 2024 and Provides Corporate Update

May 10 08:14 ET

Analyst Rating

Updated: Nov 14, 2024

Buy

Buy
100.00%
Hold
0.00%
Sell
0.00%

Price Target

No Data

Heat List

Overall